ELCELYX THERAPEUTICS, INC.

Profile

Company Names

ELCELYX THERAPEUTICS, INC.

Addresses

3033 SCIENCE PARK ROAD, SUITE 230, SAN DIEGO, CA 92121

11975 EL CAMINO REAL, SUITE 305, SAN DIEGO, CA 92130

11995 EL CAMINO REAL, SUITE 305, SAN DIEGO, CA 92130

11995 EL CAMINO REAL, SAN DIEGO, CA 92130

11995 EL CAMINO REAL, SUITE 305, SAN DIEGO, CA 92130

12730 HIGH BLUFF DR., SUITE 120, SAN DIEGO, CA 92130

Phone Numbers

(858) 876-1814
(858)344-2816

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2009

State Incorporated:

DELAWARE

Total Amount Raised:

$73,437,798.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2018-10-24 
$476,484.00 
$1,000,000.00 
$523,516.00 
Debt 
5
2015-09-25 
$20,092,879.00 
$40,185,762.00 
$20,092,883.00 
Equity 
4
2015-02-04 
$5,823,326.00 
$9,000,000.00 
$3,176,674.00 
Equity 
3
2013-02-13 
$24,720,101.00 
$24,720,101.00 
$0.00 
Equity 
2
2011-01-11 
$21,125,008.00 
$21,125,008.00 
$0.00 
Equity 
1
2010-03-02 
$1,200,000.00 
$2,200,000.00 
$1,000,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ALAIN 
 
BARON 
EXECUTIVE OFFICER, DIRECTOR
ESCIENT PHARMACEUTICALS INC   |  ELCELYX THERAPEUTICS, INC.
ALAIN 
D. 
BARON 
EXECUTIVE OFFICER, DIRECTOR
ELCELYX THERAPEUTICS, INC.
RICHARD 
 
BARRY 
DIRECTOR
ELCELYX THERAPEUTICS, INC.   |  ROUND 2 HOLDINGS, LLC
RICHARD 
J. 
BARRY 
DIRECTOR
BLACK BEAR FUND II LLC   |  ELCELYX THERAPEUTICS, INC.   |  SAREPTA THERAPEUTICS, INC.
MARTIN 
R. 
BROWN 
EXECUTIVE OFFICER
ELCELYX THERAPEUTICS, INC.
BROOK 
 
BYERS 
EXECUTIVE OFFICER, DIRECTOR
OPTIMEDICA CORP   |  HX DIAGNOSTICS INC   |  CRESCENDO BIOSCIENCE, INC.   |  CARDIODX INC   |  VERACYTE, INC.   |  FIVE PRIME THERAPEUTICS INC   |  XDX, INC.   |  ELCELYX THERAPEUTICS, INC.   |  FOUNDATION MEDICINE, INC.   |  OCULEVE, INC.   |  ENJOY TECHNOLOGY, INC.   |  ZEPHYR HEALTH, INC.   |  NEWSELA, INC.   |  CAREDX, INC.   |  CELL DESIGN LABS, INC.   |  GRAIL, INC.   |  OCTAVE BIOSCIENCE INC   |  EPIODYNE, INC.   |  ARSENAL BIOSCIENCES, INC.
RALPH 
E. 
CHRISTOFFERSEN 
DIRECTOR, EXECUTIVE OFFICER
STEMGENT INC   |  ELCELYX THERAPEUTICS, INC.   |  STEMGENT, INC.   |  TRAGARA PHARMACEUTICALS, INC.   |  LIGHTSTONE VENTURES, L.P.   |  LIGHTSTONE VENTURES (A), L.P.   |  LIGHTSTONE VENTURES (AIV), L.P.   |  LIGHTSTONE VENTURES (A) (AIV), L.P.   |  CALITHERA BIOSCIENCES, INC.
RALPH 
E. 
CHRISTOFFERSON 
DIRECTOR
ELCELYX THERAPEUTICS, INC.
MARK 
 
FINEMAN 
EXECUTIVE OFFICER
ELCELYX THERAPEUTICS, INC.
JIM 
 
GLASHEEN 
DIRECTOR
TRANSCEND MEDICAL INC   |  REVANCE THERAPEUTICS, INC.   |  INCLINE THERAPEUTICS, INC.   |  ELCELYX THERAPEUTICS, INC.   |  FORSIGHT VISION5, INC.   |  CLADE THERAPEUTICS, INC.
GINGER 
 
GRAHAM 
DIRECTOR
ELCELYX THERAPEUTICS, INC.
BOSUN 
 
HAU 
DIRECTOR
SOLX INC   |  VASCULAR PATHWAYS INC   |  AMBIO HOLDINGS, INC.   |  SOLX EUROPE LTD   |  ALPHAEON CORP   |  ELCELYX THERAPEUTICS, INC.   |  ZELEGENT, INC.   |  WUGEN, INC.
CHRISTOPHER 
R. G. 
JONES 
EXECUTIVE OFFICER
ELCELYX THERAPEUTICS, INC.
THEODORE 
A. 
LAUFIK 
EXECUTIVE OFFICER, DIRECTOR
RA PHARMACEUTICALS, INC.   |  ELCELYX THERAPEUTICS, INC.
SANDY 
 
MAHATME 
DIRECTOR
ELCELYX THERAPEUTICS, INC.
CHRISTOFFERSEN 
 
RALPH 
DIRECTOR
ELCELYX THERAPEUTICS, INC.
JAY 
 
SHERWOOD 
EXECUTIVE OFFICER
ELCELYX THERAPEUTICS, INC.
LIANG 
 
TSUI 
DIRECTOR
ELCELYX THERAPEUTICS, INC.
MARK 
 
WIGGINS 
EXECUTIVE OFFICER
OCP COLLECTIVE CORP.   |  ELCELYX THERAPEUTICS, INC.   |  SELECTION, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2018-11-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-10-24 
2015-10-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-09-25 
2015-02-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-02-04 
2014-02-21
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-02-13 
2013-02-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-02-13 
2012-12-20
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-01-11 
2012-08-13
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-01-11 
2011-05-10
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-01-11 
2011-01-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-01-11 
2010-03-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-03-02 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#